Actuate Therapeutics, Inc. Deferred State and Local Income Tax Expense (Benefit)
Actuate Therapeutics, Inc. (ACTU) reported Deferred State and Local Income Tax Expense (Benefit) of -$68.96 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit · last filed 2026-03-26
- Actuate Therapeutics, Inc. deferred state and local income tax expense (benefit) for fiscal 2025 was -$68.96K.
- Actuate Therapeutics, Inc. deferred state and local income tax expense (benefit) for fiscal 2024 was -$35.75K.
- Actuate Therapeutics, Inc. deferred state and local income tax expense (benefit) for fiscal 2023 was -$92.68K.
| Period end | Deferred State and Local Income Tax Expense (Benefit) 12 month |
|---|---|
| 2025-12-31 | -$68.96K 10-K · filed 2026-03-26 |
| 2024-12-31 | -$35.75K 10-K · filed 2026-03-26 |
| 2023-12-31 | -$92.68K 10-K · filed 2025-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B |